Opus Genetics, Inc. (IRD) Stock Analysis

Opus Genetics, Inc. (IRD) is a publicly traded company in the HEALTHCARE sector. It trades at $3.99, carries a market capitalization of $335.35M. This page summarizes the public market data, fundamentals, and frequently asked questions for IRD, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.99
• Market Cap: $335.35M
• EPS: $-1.31
• 52-Week High: $5.81
• 52-Week Low: $0.90

Market Sentiment

Opus Genetics, Inc. currently has a Neutral sentiment score of 0.11.

About Opus Genetics, Inc.

None

GNG Research Analysis

GNG Research scores Opus Genetics, Inc. (IRD) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IRD.

Frequently Asked Questions

Does IRD pay dividends?

Opus Genetics, Inc. (IRD) does not currently pay a regular dividend.

What is IRD's market cap?

Opus Genetics, Inc. (IRD) has a market capitalization of $335.35M with a current stock price of $3.99.